The purpose of the Boston University Alzheimer's Disease Core Center (BU) ADCC) is to promote research concerning Alzheimer's Disease (AD) at Boston University and throughout the country by providing information and materials from well characterized and unique patient and caregiver populations: the ambulatory and late-stage suburban population at the Bedford VA Medical Center and the racially, ethnically, and culturally diverse poor urban population served by the Boston University Hospital Home Medical Service (HMS). All patients enrolled in the Clinical Core will be assessed every six months with a comprehensive neuropsychological test battery. A neurological examination will be performed annually and blood will be obtained to isolate DNA for molecular genetic studies and stored. A detailed family history will be obtained and caregivers will be assessed yearly. The database will allow for longitudinal comparisons and the ability to correlate the progression of AD with its impact on caregivers. The Neuropathology Core will establish accurate pathological diagnoses, rigorous documentation and quantitation of neuropathological changes, produce endothelial cell lines, and collect, store and disburse postmortem tissues. The Education and Information Transfer Core will provide a comprehensive program of AD research development, dissemination, and utilization for professional caregivers with respect to symptom management. The BU ADCC will fund pilot projects to promote new AD research and foster the development of new AD investigators. The BU ADCC will closely cooperate with, and complement, the Massachusetts Alzheimer's Disease Research Center and other national Alzheimer centers. These multiple activities will be coordinated by the Administrative Core. Research in AA at Boston University is substantial in all areas, from basic molecular biology through health services research. The ADCC will strengthen existing research and create new research alliances across BU sites. It will greatly facilitate basic research on the pathogenesis of AD, applied research on patient management strategies, and research concerning the impact of disease burden on caregivers and society. In addition, it will help foster the integration of basic and applied research to better understand the biological basis of clinical symptoms.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG013846-03S2
Application #
2841976
Study Section
Special Emphasis Panel (ZAG1 (30))
Project Start
1996-07-01
Project End
2001-06-30
Budget Start
1998-08-01
Budget End
1999-06-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Boston University
Department
Neurology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Christensen, Kurt D; Uhlmann, Wendy R; Roberts, J Scott et al. (2018) A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med 20:132-141
Farrar, Danielle C; Mian, Asim Z; Budson, Andrew E et al. (2018) Functional brain networks involved in decision-making under certain and uncertain conditions. Neuroradiology 60:61-69
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6
Morrison, Filomene G; Miller, Mark W; Wolf, Erika J et al. (2018) Reduced interleukin 1A gene expression in the dorsolateral prefrontal cortex of individuals with PTSD and depression. Neurosci Lett 692:204-209
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Guenette, Jeffrey P; Stern, Robert A; Tripodis, Yorghos et al. (2018) Automated versus manual segmentation of brain region volumes in former football players. Neuroimage Clin 18:888-896
Apicco, Daniel J; Ash, Peter E A; Maziuk, Brandon et al. (2018) Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo. Nat Neurosci 21:72-80
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 791 publications